INMUNE BIO INC (INMB)
US45782T1051 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -30.01M | -27.30M | -30.34M | -12.10M | -7.68M | |||
| Change In Working Capital | 10.44M | -2.86M | -3.09M | 40.00K | -260.00K | |||
| Interest Paid | 1.78M | 1.37M | 560.00K | 0.00 | 0.00 | |||
| Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other non cash items | 7.59M | 7.48M | 4.92M | 3.11M | 2.55M | |||
| OPERATING CASH FLOW | -11.98M | -22.69M | -28.50M | -8.94M | -5.38M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -15.00M | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | 0.00 | -15.00M | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -5.00M | 0.00 | 14.95M | N/A | N/A | |||
| Stock Issued/Repurchased | 775.00K | 730.00K | 81.41M | 23.90M | 12.21M | |||
| FINANCING CASH FLOW | -4.22M | 730.00K | 96.36M | 23.90M | 12.21M | |||
| Exchange Rate Effect | -100.00K | -700.00K | -10.00K | 20.00K | -20.00K | |||
| CHANGE IN CASH | -16.30M | -22.66M | 52.85M | 14.97M | 6.81M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -11.98M | -22.69M | -28.50M | -8.94M | -5.38M | |||
| Capital Expenditure | N/A | 0.00 | -15.00M | N/A | N/A | |||
| FREE CASH FLOW | -11.98M | -22.69M | -43.50M | -8.94M | -5.38M | |||
All data in USD